focus -WSS

focus

author：Wikipedia 2025-08-28 13:06:09 - browse：2

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Physician executives need more than on

leisure time

knowledge

WSS

What AAP's gender

FDA authorizes Novavax’s updated Covid

FDA authorizes Novavax’s updated Covid

CDC advisory panel says seniors 'may' get RSV vaccine

Winners, losers from Medicare’s list of drugs subject to price talks

FDA authorizes Novavax’s updated Covid

entertainment

focus

entertainment

Drug repurposing or repositioning? The language matters

Complete sequence of Y chromosome published for first time

What does generative AI mean for health care? We asked experts

Was Amgen transparent enough on FDA's concern on cancer drug?

United colonoscopy coverage change 'may cost lives,' doctors say

Why more medical students aren't specializing in primary care

Cancer drug shortages should be causing more outrage

Neuroscience startup Neumora files for IPO

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Why more medical students aren't specializing in primary care

entertainment

Departing Stanford president retracts two papers

AstraZeneca challenges Medicare drug negotiation program

NYU Langone launches private ChatGPT for its health care data

What to expect at HLTH 2023, the health care industry conference

FDA rejects Alnylam's heart disease treatment over insufficient data

Chan Zuckerberg Biohub Chicago to focus on inflammation

leisure time

knowledge

focus

focus